MD · MAS · PhD Epidemiology & Translational Science · Computational Precision Health · National Polytechnic Institute · UCSF / UC Berkeley

Where Clinical Judgment Meets Computational Precision

I'm Eduardo Rodriguez, a physician and PhD epidemiologist who designs clinical AI systems and research pipelines that work because they're built with scientific rigor, not just technical skill.

Portrait of Eduardo Rodriguez Almaraz

I work at the intersection of three disciplines I refuse to simplify into one.

I trained as a physician and practiced general and family medicine before pursuing an MAS in Clinical Research and a PhD in Epidemiology & Translational Science with an emphasis in Computational Precision Health.

Today I design and deploy clinical AI systems and research pipelines for groups that need someone fluent in all three languages — clinical context, methodological rigor, and production engineering.

The Clinician-Scientist

Trained as a physician with hands-on experience in general and emergency medicine. I understand what a clinical finding means before I model it — and I apply that lens to every research question and system I design.

The Epidemiologist

PhD in Epidemiology & Translational Science, MAS in Clinical Research. Every pipeline I build is designed with the same methodological rigor I'd bring to a clinical trial — from study design through endpoint derivation.

The Builder

I design and deploy LLM systems, automate clinical research workflows, and build data pipelines — end to end, in production, not just in notebooks.

CLINICAL AI · WOMEN'S HEALTH · LLM DEPLOYMENT

Agentic Clinical Intake System

Upturn Health · Deployed · 2025

Designed and deployed a five-phase agentic LLM system for a women's health startup — integrating safety screening, adaptive conversation logic, and clinical protocol alignment.

Stack: Python · LLMs · YAML

PYTHON · EHR · SURVIVAL ANALYSIS · CDISC

Automated Oncology Research Pipeline

UCSF · Research · UCSF

Automated pipelines for oncology research data processing — from EHR extraction through endpoint derivation (OS, PFS, RANO, Genetic variants) to analysis-ready datasets.

Stack: Python · EHR · NGS

CLINICAL TRIALS · DATA INFRASTRUCTURE · CLINICAL OPERATIONS

Clinical Operations Dashboards

Regeneron · Deployed

Built and deployed internal analytical tools used daily by clinical operations teams at Regeneron — a portfolio-level enrollment monitoring dashboard tracking trial status across the company's portfolio, and a subject-level data completeness dashboard. Designed to answer the specific operational question at hand, not to be general-purpose tools.

Stack: Python · Streamlit · SQL

I collaborate with clinical teams, research groups, and health technology companies that need someone who can move between the science, the clinical context, and the implementation. I build, I analyze, and I stay accountable to the evidence.

Clinical AI Translation

You have a clinical problem and an AI team that doesn't speak the same language. I bridge that gap — defining requirements from a physician-scientist perspective, designing systems that are clinically valid, and ensuring outputs are interpretable and defensible.

Research Automation & Pipeline Design

Clinical research teams spending weeks on data wrangling, endpoint derivation, or manual extraction. I design automated pipelines — LLM-powered and traditional — that accelerate timelines without sacrificing rigor.

Get in touch

[2025]

Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival

Rodriguez Almaraz E, Solomon D, et al. · Neuro-Oncology Advances · 2025

Genomic profiling of 205 IDH-mutant astrocytomas revealed that RAS-MAPK pathway alterations are enriched in recurrent, high-grade gliomas and associated with inferior survival, implicating this pathway as a key driver of malignant transformation and a potential therapeutic target.

First Author First AuthorNeuro-OncologyRAS-MAPKIDH-mutant Glioma
[2024]

Generation of guideline-based clinical decision trees in oncology using large language models

Miao B, Rodriguez Almaraz E, Butte A, et al. · medRxiv (preprint) · 2024

GPT-4 and Claude-2 were both capable of generating clinically valid molecular subtyping decision trees across five cancer types, though adding expert-curated guideline text offered only modest accuracy gains — suggesting LLMs hold real promise for distilling oncologic diagnostic frameworks but require careful oversight before clinical deployment.

Second Author Preprint Second AuthorClinical AILLM